To review the prevalence of the metabolic syndrome and type 2 diabetes in children and adolescents. METHOD: Literature review. RESULTS: It is well demonstrated that cardiovascular risk factors are frequent in childhood obesity and they tend to cluster. However, the frequency of the metabolic syndrome in childhood and adolescence has been investigated only by few studies. In spite of the diverse criteria used for defining the metabolic syndrome, it is evident that the syndrome is already highly prevalent among obese children and adolescents. Population-based data suggest that the epidemic of pediatric obesity is being followed by an increase of type 2 diabetes mellitus, especially in the United States and in minorities. For the European countries, there are no population-based incidence and prevalence data concerning type 2 diabetes mellitus in children and adolescents. From the available data, the magnitude of the problem in the European Caucasian population seems to be much less than in North America. CONCLUSION: There is an urgent need to establish internationally acceptable criteria for the metabolic syndrome in children and adolescents and to commence screening for this syndrome. Although type 2 diabetes mellitus is still rare among European children, screening is recommended for type 2 diabetes mellitus or impaired glucose tolerance in children and especially in adolescents with substantial risk for the development of this disease.
Introduction
People with the metabolic syndrome are at increased risk for developing diabetes mellitus and cardiovascular diseases, 1 the number one killer in the adult population of Western societies. Obesity plays a central role in the metabolic syndrome, which includes hyperinsulinemia/insulin resistance, hypertension and dyslipidemia. Recent studies indicate that the process of atherosclerosis starts at an early age and is already linked to obesity and other components of the metabolic syndrome in childhood. 2 Parallel with the obesity epidemic, the incidence of type 2 diabetes mellitus in children has increased alarmingly and the presence of the metabolic syndrome in children and adolescents has also been reported. 3 The aim of the present paper is to review the data concerning the prevalence of the metabolic syndrome and type 2 diabetes mellitus during childhood and adolescence.
The metabolic syndrome
Historical background and definition It has long been realized that certain metabolic symptoms often occur together, and that these symptoms predict the development of diseases. The combination of hypertension, hyperglycemia and hyperuricemia was reported as early as the 1920s. There is now substantial evidence that resistance to insulin-stimulated glucose uptake is a common phenomenon, associated with glucose intolerance, dyslipidemia, high blood pressure and coronary heart disease. Furthermore, these metabolic abnormalities tend to cluster together in the same individual. Although several clinicians and researchers had seen such a syndrome previously, it was probably Reaven 4 who suggested in the late 1980s (last century) the existence of a syndrome in which insulin resistance was the primary defect, associated with hyperinsulinemia. He also proposed that the insulin resistance syndrome be titled Syndrome X. Later this syndrome was strongly associated with other metabolic aberrations, most notably with visceral obesity, and called 'the deadly quartet', the GHO syndrome (glucose intolerance, hypertension and obesity) or the metabolic cardiovascular syndrome. , hypertension, hyperinsulinemia/insulin resistance, IGT/type 2 diabetes mellitus and dyslipidemia (hypertriglyceridemia, low HDL cholesterol). However, the cutoff values generally differ from study to study and abdominal obesity is not well defined (if included among the criteria) since no international waist circumference and WHR standards exist for children.
Prevalence of the metabolic syndrome Several studies have investigated the prevalence of the metabolic syndrome in adults. According to the results of Ford et al 8 and Meigs et al, 9 the sex-and age-adjusted prevalence of the metabolic syndrome in the US population was 23.7 and 24%, respectively, which was influenced significantly by age, sex and race. A large family study of type 2 diabetes in Finland and Sweden found the prevalence of the metabolic syndrome to be 15% among men and 10% among women with normal glucose tolerance, and 64% among men and 42% among women with glucose intolerance. 1 The gross prevalence of the metabolic syndrome in Porto was 14.5% after age-adjustment. 10 These data from the US and Europe clearly demonstrate that the metabolic syndrome is highly prevalent in the adult population, which may have important health-care implications. The prevalence of cardiovascular risk factors in childhood obesity and the clustering of these risk factors have been studied extensively (for a review see Reilly et al
11
). All studies demonstrated that the cardiovascular risk factors are more prevalent in obese than in nonobese children and that they tend to cluster. For example, Freedman et al 12 reported
significant odds ratio in obese children for raised diastolic blood pressure (OR 2.4), raised systolic blood pressure (OR 4.5), raised LDL cholesterol (OR 3.0), low HDL cholesterol (OR 3.4), raised triglycerides (OR 7.1) and high fasting insulin concentration (OR 12.1). In the same study, Freedman and co-workers also found that 58% of obese 5-10 y olds had at least one of these five cardiovascular risk factors, and 25% had two or more. There were only a few studies that gave a clear definition of childhood metabolic syndrome and investigated the prevalence of the syndrome as a primary goal 3, 13, 14 (Table 1) .
Unfortunately, the results of these studies are not comparable since the definitions they used for the childhood metabolic syndrome were different.
Conclusion
The common message of the reviewed studies is that the metabolic syndrome is already detectable in children, especially in obese children and its prevalence is consider- 18, 19 ( Table 2 ) and screening recommendation 18 (Table 3) , consensus has been reached.
Prevalence of type 2 diabetes mellitus in children
Although type 1 diabetes remains the main form of diabetes in the young, the much less common, inherited forms of diabetes, and type 2 diabetes mellitus (T2DM) can also present in early life. T2DM in children and adolescents is regarded as an emerging problem; however, there are only few reliable reports of its true population prevalence or its prevalence in obese children. Population-based data suggest that the epidemic of pediatric obesity is being followed by an increase of the incidence and prevalence of type 2 diabetes mellitus. The American Diabetes Association (ADA) has issued a consensus statement on T2DM in youth, stating that 8-45% of newly diagnosed DM children had nonimmune-mediated diabetes. 18 The phenomenon of a rapidly rising incidence of T2DM in young patients is well known in North America.
17 T2DM
now accounts for as many as 8-46% of new cases of pediatric diabetes and affects up to 5% of adolescents in some Native American tribes. 17, 20 However, the emergence of T2DM in children is not limited to this country. Among Japanese junior high school-aged youngsters, 21 the incidence of T2DM increased from 7.2/100.000 in 1976-1980 to 13.9/ 100.000 in 1991-1995. The annual incidence of T2DM was Table 2 Criteria for the diagnosis of diabetes mellitus 18 1. Symptoms of diabetes plus casual plasma glucose concentration Z200 mg/dl (11.1 mmol/l). Casual is defined as any time of day without regard to time since the last meal. The classic symptoms of diabetes include polyuria, polydipsia and unexplained weight loss. Or 2. FPG (fasting plasma glucose) Z126 mg/dl (7.0 mmol/l). Fasting is defined as no caloric intake for at least 8 h.
Or 3. The 2-h PG (plasma glucose) Z200 mg/dl (11.1 mmol/l) during OGTT. The test should be performed as described by WHO, 19 using a glucose load containing the equivalent of 75-g anhydrous glucose dissolved in water.
In the absence of unequivocal hyperglycemia with acute metabolic decomposition, these criteria should be confirmed by repeat testing on a different day. The third measure (OGTT) is not recommended for routine clinical use. FPG Z110 mg/dl (6.1 mmol/l) ¼ fasting glucose (IFG) 2-h PGZ7.8 mmol/l and o200 mg/dl (11.1 mmol/l) ¼ impaired glucose tolerance (IGT). A total of 31 (0.5%) cases of T2DM out of approximately 6000 cases of children with diabetes were found in Sweden. 28 Of these cases, 55% were of ethnic minorities known to have high incidence of T2DM and male to female ratio was 1:2.
Data on the incidence of T2DM in children from the eastern and central Europe are even scarcer. In the multicenter trial on metformin in pediatric patients with T2DM, 29 besides 62 children from US, 16 children from Russia, four from Ukraine, two from Belarus and one from Poland were included. Their age ranged from 10 to 17 y and over 80% were obese or overweight.
According to our results 30 
Conclusion
On the basis of the available data, it seems very likely that the prevalence of T2DM in European children is not as high as it is in North America, although an increase in its prevalence and incidence can be expected. The crude prevalence of T2DM as compared to type 1 diabetes mellitus in children younger than 18 y is still negligible.
